BioSpace News Archive

Torrey Pines Investment announced today that Snap Bio, Inc. has joined its early drug discovery ecosystem through its i2020 Accelerator specialty investment framework, which includes a three-way partnership with ChemDiv, Inc.

NeuroVive Pharmaceutical AB announced today that the company has been awarded SEK 1.5 million as a first tranche of total SEK 5 million in funding from Vinnova, Sweden’s innovation agency, and the Swelife call, for intensified development in the NVP015 project, the goal of which is to advance the candidate compound NV354 to clinical studies.

Shanghai Hi-Tech Nutraceuticals also has rights to synthetic alkaloids of Senegalia.

Arena will receive $800M upfront, and is eligible to receive low double-digit tiered royalties, plus up to $400M in milestone payments

Mr. Zavodnick has over 20 years of leadership experience in the biopharmaceutical industry.

Study shows viability of taking once-weekly pill

Initial Study Results Show a Single Oral Dose is Expected to Have Similar Pharmacokinetic Parameters as IV Infusion

Many asthma patients are prescribed oral corticosteroids (OCS) to treat moderate-to-severe flares and decrease the risk of emergency department (ED) visits or hospitalizations, but with chronic use comes the potential for serious health risks.

Kali, Inc. (USOTC: KALY) today announced finalizing the acquisition of NCM Biotech.

PolarityTE, Inc. (Nasdaq: PTE), announced today that it will attend and present at the Piper Jaffray 30th Annual Healthcare Conference